处方药需要进行风险评估和缓解策略:患者对风险沟通的看法以及教育材料的价值
Susan Chimonas1, Carol Cosenza2, Aaron S Kesselheim3
1Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York, NY, USA. chimonas@mskcc.org.
患者经常误解风险评估和缓解策略 (REMS) 材料,尽管他们感觉了解药物风险. 改进沟通策略和教育文件对于更好地理解和遵守REMS要求至关重要.
科学领域:
- 药物监督 药物监督 药物监督
- 患者教育 患者教育
- 卫生沟通健康沟通
背景情况:
- 风险评估和缓解策略 (REMS) 计划是FDA对具有严重副作用的药物进行授权的.
- 雷姆斯材料旨在向患者和护理人员提供有关药物风险和计划要求的信息.
研究的目的:
- 评估REMS材料在传达药物风险信息和计划要求方面的有效性.
- 确定患者和护理人员对风险沟通的偏好.
主要方法:
- 进行了定性采访,对那些被处方REMS覆盖药物的患者和照顾者进行了采访.
- 面试成绩单是手工编码的,闭式问题是分表的.
主要成果:
- 参与者经常误解REMS报名表,将其视为法律保护而不是安全措施.
- 虽然大多数参与者觉得了解药物风险,但关于REMS特定风险和安全使用理由存在知识差距.
- 患者和护理人员的偏好各不相同,大多数人倾向于从提供者那里获得口头信息,并补充视觉辅助和摘要.
结论:
- 在了解REMS程序和相关药物风险方面的差距需要对当前的沟通材料和策略进行审查.
- 更清晰,更简洁,更全面的教育文件可以提高患者和护理人员的理解和遵守REMS要求.
更多相关视频
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
08:21Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Dosage Regimen: Individualization
Drug Dosing: Geriatric Patients
Dosage Regimens: Designs and Approaches
Factors Affecting Drug Response: Overview
